Trial Outcomes & Findings for A Comparison of 5 Low Volume Bowel Preparations (NCT NCT01719653)

NCT ID: NCT01719653

Last Updated: 2017-03-24

Results Overview

The quality of the colon preparation as graded using our new Chicago Bowel Preparation Scale (BPS) (Adventist Midwest Region Institutional Review Board, AMH 2010-01-80; ClinicalTrials.gov NCT01063049). Chicago BPS total score is ranges from 0 (very poor) to 36 (outstanding). Modified Chicago BPS total score is ranges from 0 (very poor) to 33 (outstanding). Chicago BPS Fluid score is ranges from 0 (dry) to 3 (wet).

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

1079 participants

Primary outcome timeframe

At completion of colonoscopy - day 1

Results posted on

2017-03-24

Participant Flow

Participant milestones

Participant milestones
Measure
MiraLAX 306 g (Day-Prior)
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 51 g at 12 noon; Gatorade 64 oz mixed with Miralax 255 g from about 6 PM to 9 PM MiraLAX: MiraLAX consumed as described in each arm. Gatorade: Gatorade consumed as described in each arm.
MiraLAX 357 g (Day-Prior)
MiraLAX 357 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 68 g at 12 noon; Gatorade 64 oz mixed with Miralax 289 g from about 6 PM to 9 PM. MiraLAX: MiraLAX consumed as described in each arm. Gatorade: Gatorade consumed as described in each arm.
MiraLAX 306 g (Split-Dose)
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed as a split-dose as follows: Gatorade 32oz mixed with Miralax 153 g from about 6 PM to 8 PM the day prior to the colonoscopy; Gatorade 32oz mixed with Miralax 153 g from about 2-4 hours prior to the colonoscopy. MiraLAX: MiraLAX consumed as described in each arm. Gatorade: Gatorade consumed as described in each arm.
MoviPrep (Split-Dose)
MoviPrep consumed as a split-dose as follows: MoviPrep 1 liter consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 0.5 liter of clear liquids; MoviPrep 1 liter consumed from 3-4 hours prior to the colonoscopy followed by 0.5 liter of clear liquids. MoviPrep: MoviPrep consumed as described in each arm.
SUPREP (Split-Dose)
SUPREP consumed as a split-dose as follows: SUPREP 16 oz consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 32 oz of clear liquids; SUPREP 16 oz consumed from 3-4 hours prior to the colonoscopy followed by 32 oz of clear liquids. SUPREP: SUPREP consumed as described in each arm.
Overall Study
STARTED
209
213
218
218
221
Overall Study
COMPLETED
200
200
200
200
200
Overall Study
NOT COMPLETED
9
13
18
18
21

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

A Comparison of 5 Low Volume Bowel Preparations

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
MiraLAX 306 g (Day-Prior)
n=200 Participants
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 51 g at 12 noon; Gatorade 64 oz mixed with Miralax 255 g from about 6 PM to 9 PM MiraLAX: MiraLAX consumed as described in each arm. Gatorade: Gatorade consumed as described in each arm.
MiraLAX 357 g (Day-Prior)
n=200 Participants
MiraLAX 357 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 68 g at 12 noon; Gatorade 64 oz mixed with Miralax 289 g from about 6 PM to 9 PM. MiraLAX: MiraLAX consumed as described in each arm. Gatorade: Gatorade consumed as described in each arm.
MiraLAX 306 g (Split-Dose)
n=200 Participants
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed as a split-dose as follows: Gatorade 32oz mixed with Miralax 153 g from about 6 PM to 8 PM the day prior to the colonoscopy; Gatorade 32oz mixed with Miralax 153 g from about 2-4 hours prior to the colonoscopy. MiraLAX: MiraLAX consumed as described in each arm. Gatorade: Gatorade consumed as described in each arm.
MoviPrep (Split-Dose)
n=200 Participants
MoviPrep consumed as a split-dose as follows: MoviPrep 1 liter consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 0.5 liter of clear liquids; MoviPrep 1 liter consumed from 3-4 hours prior to the colonoscopy followed by 0.5 liter of clear liquids. MoviPrep: MoviPrep consumed as described in each arm.
SUPREP (Split-Dose)
n=200 Participants
SUPREP consumed as a split-dose as follows: SUPREP 16 oz consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 32 oz of clear liquids; SUPREP 16 oz consumed from 3-4 hours prior to the colonoscopy followed by 32 oz of clear liquids. SUPREP: SUPREP consumed as described in each arm.
Total
n=1000 Participants
Total of all reporting groups
Age, Continuous
60.9 years
STANDARD_DEVIATION 12.7 • n=5 Participants
61.3 years
STANDARD_DEVIATION 12.4 • n=7 Participants
59.1 years
STANDARD_DEVIATION 11.3 • n=5 Participants
60.1 years
STANDARD_DEVIATION 11.4 • n=4 Participants
60.6 years
STANDARD_DEVIATION 11.2 • n=21 Participants
60.4 years
STANDARD_DEVIATION 11.8 • n=10 Participants
Sex: Female, Male
Female
99 Participants
n=5 Participants
99 Participants
n=7 Participants
101 Participants
n=5 Participants
97 Participants
n=4 Participants
99 Participants
n=21 Participants
495 Participants
n=10 Participants
Sex: Female, Male
Male
101 Participants
n=5 Participants
101 Participants
n=7 Participants
99 Participants
n=5 Participants
103 Participants
n=4 Participants
101 Participants
n=21 Participants
505 Participants
n=10 Participants
Region of Enrollment
United States
200 participants
n=5 Participants
200 participants
n=7 Participants
200 participants
n=5 Participants
200 participants
n=4 Participants
200 participants
n=21 Participants
1000 participants
n=10 Participants

PRIMARY outcome

Timeframe: At completion of colonoscopy - day 1

The quality of the colon preparation as graded using our new Chicago Bowel Preparation Scale (BPS) (Adventist Midwest Region Institutional Review Board, AMH 2010-01-80; ClinicalTrials.gov NCT01063049). Chicago BPS total score is ranges from 0 (very poor) to 36 (outstanding). Modified Chicago BPS total score is ranges from 0 (very poor) to 33 (outstanding). Chicago BPS Fluid score is ranges from 0 (dry) to 3 (wet).

Outcome measures

Outcome measures
Measure
MiraLAX 306 g (Day-Prior)
n=200 Participants
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 51 g at 12 noon; Gatorade 64 oz mixed with Miralax 255 g from about 6 PM to 9 PM MiraLAX: MiraLAX consumed as described in each arm. Gatorade: Gatorade consumed as described in each arm.
MiraLAX 357 g (Day-Prior)
n=200 Participants
MiraLAX 357 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 68 g at 12 noon; Gatorade 64 oz mixed with Miralax 289 g from about 6 PM to 9 PM. MiraLAX: MiraLAX consumed as described in each arm. Gatorade: Gatorade consumed as described in each arm.
MiraLAX 306 g (Split-Dose)
n=200 Participants
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed as a split-dose as follows: Gatorade 32oz mixed with Miralax 153 g from about 6 PM to 8 PM the day prior to the colonoscopy; Gatorade 32oz mixed with Miralax 153 g from about 2-4 hours prior to the colonoscopy. MiraLAX: MiraLAX consumed as described in each arm. Gatorade: Gatorade consumed as described in each arm.
MoviPrep (Split-Dose)
n=200 Participants
MoviPrep consumed as a split-dose as follows: MoviPrep 1 liter consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 0.5 liter of clear liquids; MoviPrep 1 liter consumed from 3-4 hours prior to the colonoscopy followed by 0.5 liter of clear liquids. MoviPrep: MoviPrep consumed as described in each arm.
SUPREP (Split-Dose)
n=200 Participants
SUPREP consumed as a split-dose as follows: SUPREP 16 oz consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 32 oz of clear liquids; SUPREP 16 oz consumed from 3-4 hours prior to the colonoscopy followed by 32 oz of clear liquids. SUPREP: SUPREP consumed as described in each arm.
Chicago Bowel Preparation Scale
Chicago BPS Total Score
33.54 units on a scale
Standard Deviation 4.28
34.00 units on a scale
Standard Deviation 4.25
34.67 units on a scale
Standard Deviation 3.58
34.95 units on a scale
Standard Deviation 3.39
35.16 units on a scale
Standard Deviation 2.34
Chicago Bowel Preparation Scale
Modified Chicago BPS Total Score
31.82 units on a scale
Standard Deviation 3.59
32.14 units on a scale
Standard Deviation 3.69
32.33 units on a scale
Standard Deviation 2.93
32.54 units on a scale
Standard Deviation 2.92
32.65 units on a scale
Standard Deviation 1.72
Chicago Bowel Preparation Scale
Chicago BPS Fluid Score
0.90 units on a scale
Standard Deviation 0.83
1.03 units on a scale
Standard Deviation 0.89
1.84 units on a scale
Standard Deviation 0.90
1.45 units on a scale
Standard Deviation 0.82
1.30 units on a scale
Standard Deviation 0.91

SECONDARY outcome

Timeframe: At completion of colonoscopy - day 1

The quality of the colon preparation as graded using Boston Bowel Preparation total scores is range from 0 (very poor) to 9 (outstanding).

Outcome measures

Outcome measures
Measure
MiraLAX 306 g (Day-Prior)
n=200 Participants
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 51 g at 12 noon; Gatorade 64 oz mixed with Miralax 255 g from about 6 PM to 9 PM MiraLAX: MiraLAX consumed as described in each arm. Gatorade: Gatorade consumed as described in each arm.
MiraLAX 357 g (Day-Prior)
n=200 Participants
MiraLAX 357 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 68 g at 12 noon; Gatorade 64 oz mixed with Miralax 289 g from about 6 PM to 9 PM. MiraLAX: MiraLAX consumed as described in each arm. Gatorade: Gatorade consumed as described in each arm.
MiraLAX 306 g (Split-Dose)
n=200 Participants
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed as a split-dose as follows: Gatorade 32oz mixed with Miralax 153 g from about 6 PM to 8 PM the day prior to the colonoscopy; Gatorade 32oz mixed with Miralax 153 g from about 2-4 hours prior to the colonoscopy. MiraLAX: MiraLAX consumed as described in each arm. Gatorade: Gatorade consumed as described in each arm.
MoviPrep (Split-Dose)
n=200 Participants
MoviPrep consumed as a split-dose as follows: MoviPrep 1 liter consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 0.5 liter of clear liquids; MoviPrep 1 liter consumed from 3-4 hours prior to the colonoscopy followed by 0.5 liter of clear liquids. MoviPrep: MoviPrep consumed as described in each arm.
SUPREP (Split-Dose)
n=200 Participants
SUPREP consumed as a split-dose as follows: SUPREP 16 oz consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 32 oz of clear liquids; SUPREP 16 oz consumed from 3-4 hours prior to the colonoscopy followed by 32 oz of clear liquids. SUPREP: SUPREP consumed as described in each arm.
Boston Bowel Preparation Scale
8.39 units on a scale
Standard Deviation 1.36
8.57 units on a scale
Standard Deviation 1.16
8.66 units on a scale
Standard Deviation 1.16
8.80 units on a scale
Standard Deviation 1.04
8.80 units on a scale
Standard Deviation 0.77

SECONDARY outcome

Timeframe: At completion of colonoscopy - day 1

The cleanliness of the colon as rated by the gastroenterologist using an adequate/inadequate scale where an adequate preparation is defined as being able to see at least 95% of the mucosa of the colon after washing and suctioning; otherwise, the preparation is rated as inadequate.

Outcome measures

Outcome measures
Measure
MiraLAX 306 g (Day-Prior)
n=200 Participants
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 51 g at 12 noon; Gatorade 64 oz mixed with Miralax 255 g from about 6 PM to 9 PM MiraLAX: MiraLAX consumed as described in each arm. Gatorade: Gatorade consumed as described in each arm.
MiraLAX 357 g (Day-Prior)
n=200 Participants
MiraLAX 357 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 68 g at 12 noon; Gatorade 64 oz mixed with Miralax 289 g from about 6 PM to 9 PM. MiraLAX: MiraLAX consumed as described in each arm. Gatorade: Gatorade consumed as described in each arm.
MiraLAX 306 g (Split-Dose)
n=200 Participants
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed as a split-dose as follows: Gatorade 32oz mixed with Miralax 153 g from about 6 PM to 8 PM the day prior to the colonoscopy; Gatorade 32oz mixed with Miralax 153 g from about 2-4 hours prior to the colonoscopy. MiraLAX: MiraLAX consumed as described in each arm. Gatorade: Gatorade consumed as described in each arm.
MoviPrep (Split-Dose)
n=200 Participants
MoviPrep consumed as a split-dose as follows: MoviPrep 1 liter consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 0.5 liter of clear liquids; MoviPrep 1 liter consumed from 3-4 hours prior to the colonoscopy followed by 0.5 liter of clear liquids. MoviPrep: MoviPrep consumed as described in each arm.
SUPREP (Split-Dose)
n=200 Participants
SUPREP consumed as a split-dose as follows: SUPREP 16 oz consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 32 oz of clear liquids; SUPREP 16 oz consumed from 3-4 hours prior to the colonoscopy followed by 32 oz of clear liquids. SUPREP: SUPREP consumed as described in each arm.
Adequate/Inadequate Scale
Adequate
195 Participants
196 Participants
198 Participants
197 Participants
197 Participants
Adequate/Inadequate Scale
Inadequate
5 Participants
4 Participants
2 Participants
3 Participants
3 Participants

Adverse Events

MiraLAX 306 g (Day-Prior)

Serious events: 0 serious events
Other events: 119 other events
Deaths: 0 deaths

MiraLAX 357 g (Day-Prior)

Serious events: 0 serious events
Other events: 122 other events
Deaths: 0 deaths

MiraLAX 306 g (Split-Dose)

Serious events: 0 serious events
Other events: 126 other events
Deaths: 0 deaths

MoviPrep (Split-Dose)

Serious events: 0 serious events
Other events: 110 other events
Deaths: 0 deaths

SUPREP (Split-Dose)

Serious events: 0 serious events
Other events: 111 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
MiraLAX 306 g (Day-Prior)
n=200 participants at risk
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 51 g at 12 noon; Gatorade 64 oz mixed with Miralax 255 g from about 6 PM to 9 PM MiraLAX: MiraLAX consumed as described in each arm. Gatorade: Gatorade consumed as described in each arm.
MiraLAX 357 g (Day-Prior)
n=200 participants at risk
MiraLAX 357 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 68 g at 12 noon; Gatorade 64 oz mixed with Miralax 289 g from about 6 PM to 9 PM. MiraLAX: MiraLAX consumed as described in each arm. Gatorade: Gatorade consumed as described in each arm.
MiraLAX 306 g (Split-Dose)
n=200 participants at risk
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed as a split-dose as follows: Gatorade 32oz mixed with Miralax 153 g from about 6 PM to 8 PM the day prior to the colonoscopy; Gatorade 32oz mixed with Miralax 153 g from about 2-4 hours prior to the colonoscopy. MiraLAX: MiraLAX consumed as described in each arm. Gatorade: Gatorade consumed as described in each arm.
MoviPrep (Split-Dose)
n=200 participants at risk
MoviPrep consumed as a split-dose as follows: MoviPrep 1 liter consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 0.5 liter of clear liquids; MoviPrep 1 liter consumed from 3-4 hours prior to the colonoscopy followed by 0.5 liter of clear liquids. MoviPrep: MoviPrep consumed as described in each arm.
SUPREP (Split-Dose)
n=200 participants at risk
SUPREP consumed as a split-dose as follows: SUPREP 16 oz consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 32 oz of clear liquids; SUPREP 16 oz consumed from 3-4 hours prior to the colonoscopy followed by 32 oz of clear liquids. SUPREP: SUPREP consumed as described in each arm.
Gastrointestinal disorders
Nausea
32.5%
65/200
40.0%
80/200
33.0%
66/200
32.5%
65/200
35.0%
70/200
Gastrointestinal disorders
Vomiting
9.0%
18/200
11.5%
23/200
6.0%
12/200
4.0%
8/200
6.5%
13/200
Gastrointestinal disorders
Abdominal Cramps/Pain
33.0%
66/200
35.0%
70/200
34.0%
68/200
37.5%
75/200
39.0%
78/200
Gastrointestinal disorders
Bloating
59.5%
119/200
61.0%
122/200
63.0%
126/200
55.0%
110/200
55.5%
111/200

Additional Information

David Gerard, MD

Gastroenterology Services, Ltd

Phone: 630 969 1167

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place